Australia markets open in 8 hours 25 minutes

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.15+0.03 (+0.59%)
As of 11:35AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 732.26M
Enterprise value 500.88M
Trailing P/E N/A
Forward P/E 56.82
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.84
Price/book (mrq)2.04
Enterprise value/revenue 2.62
Enterprise value/EBITDA -11.96

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3-54.45%
S&P500 52-week change 325.38%
52-week high 312.43
52-week low 34.71
50-day moving average 35.18
200-day moving average 37.67

Share statistics

Avg vol (3-month) 32.15M
Avg vol (10-day) 31.5M
Shares outstanding 5143.02M
Implied shares outstanding 6143.02M
Float 8129.8M
% held by insiders 17.53%
% held by institutions 138.69%
Shares short (15 Apr 2024) 411.39M
Short ratio (15 Apr 2024) 48.02
Short % of float (15 Apr 2024) 47.90%
Short % of shares outstanding (15 Apr 2024) 47.88%
Shares short (prior month 15 Mar 2024) 410.65M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -32.69%
Operating margin (ttm)-13.06%

Management effectiveness

Return on assets (ttm)-8.10%
Return on equity (ttm)-16.69%

Income statement

Revenue (ttm)191.41M
Revenue per share (ttm)1.33
Quarterly revenue growth (yoy)46.20%
Gross profit (ttm)N/A
EBITDA -47M
Net income avi to common (ttm)-62.56M
Diluted EPS (ttm)-0.43
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)319.37M
Total cash per share (mrq)2.24
Total debt (mrq)88.54M
Total debt/equity (mrq)24.63%
Current ratio (mrq)5.61
Book value per share (mrq)2.50

Cash flow statement

Operating cash flow (ttm)-20.39M
Levered free cash flow (ttm)14.53M